Related Experiment Videos
Changing the remodeling process in heart failure: basic mechanisms and laboratory results
1Cardiology Department, Cleveland Clinic Foundation, OH 44195, USA.
Current Opinion in Cardiology
|July 3, 1998
Summary
Cardiac remodeling, a key driver of heart failure progression, involves structural changes like myocyte elongation and slippage. Research suggests these changes, particularly myocyte elongation, contribute significantly to left ventricular geometry alterations, with potential for reversal.
Area of Science:
- Cardiology
- Cell Biology
- Physiology
Background:
- Heart failure remains a leading cause of mortality and morbidity.
- Myocardial remodeling is recognized as a critical factor in heart failure progression.
- Understanding the mechanisms of cardiac remodeling is crucial for both scientists and clinicians.
Purpose of the Study:
- To investigate the role of isolated cardiac myocyte function in heart failure.
- To clarify the fundamental mechanisms underlying cardiac remodeling.
- To explore the contribution of cellular changes to the structural alterations in heart failure.
Main Methods:
- Analysis of isolated cardiac myocyte function in human cardiomyopathy and animal models of heart failure.
- Examination of cellular morphology, including myocyte shape and diameter.
- Review of existing literature on cardiac remodeling mechanisms.
Main Results:
- Studies on isolated myocytes yielded mixed and contradictory results regarding contractility.
- A consistent finding is myocyte elongation, with variable changes in transverse diameter.
- Myocyte slippage is proposed as a contributing factor to cardiac remodeling, alongside myocyte growth, collagen deposition, and cell dropout.
Conclusions:
- Structural changes in cardiac remodeling, including myocyte elongation and slippage, alter left ventricular geometry.
- Myocyte elongation appears dominant, but cannot fully explain chamber enlargement, indicating a role for myocyte slippage.
- Preliminary evidence suggests that cardiac remodeling may be reversible with interventions like left ventricular assist devices and beta-blockers.